1Penneacchio LA, Oliver M, Hubacek JA, et al . An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing[J]. Science , 2001,294 : 169-173.
2Van der Vliet HN, Sammels MG, Leegwater AC, et al . Apolipoprotein A-V :a novel apolipoprotein associated with early phase of liver regeneration[J]. J Biol Chem ,2001,276: 44512-44520.
3Alborn WE, Johnson MG, Prince MJ, et al . Definitive N-terminal proteinsequence and further characterization of the novel apolipoprotein A5 inhuman serum [J]. Clin Chem, 2006,52:514-517.
4O'Brien PJ, Alborn WE, Sloan JH, et al . The novel apoli poprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins[J]. Clin Chem ,2005,51:351-359.
5Weinberg RB, Cook VR, Beckstead JA, et al . Structure and Interracial Properties of Human Apolipoprotein A-V[J]. The Journal of Biological Chemistry , 2003,278 : 34438-34444.
6Beckstead JA, Oda MN, Martin DD, et al .Structure-Function Studies of Human Apolipoprotein A-V: A Regulator of Plasma Lipid Homeostasis[J]. Biochemistry , 2003,42 : 9416- 9423.
7Vliet HN, Sehaap FG, Levels JHM, et al . Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglyeerides and cholesterol in mice [J]. Biochemical and Biophysical Research Communications, 2002, 295: 1156- 1159.
8Wei Huang, Nan Bi, Xiaohong Zhang, et al. Overexpression of apolipoprotein AV in the liver reduces plasma triglyceride and cholesterol but not HDL in ApoE deficient mice[J]. Biochemical and Biophysical Research Communications, 2006,346 : 14-18.
9Baroukh N,Bauge E, Akiyama J, et al . Analysis of Apolipoprotein AS, C3, and Plasma Triglyceride Concentrations in Genetically Engineered Mice[J]. Arterioscler Thromb Vasc Biol , 2004,24 : 1297-1302.
10Najib JF, Bauge E, Niculescu LS, et al . Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5 [ J ]. Biochemical and Biophysical Research Communications , 2004,319:397-404.
